Apollo Medical Holdings Inc (NASDAQ:AMEH) CEO Thomas S. Lam purchased 6,900 shares of the business’s stock in a transaction dated Tuesday, June 11th. The shares were purchased at an average cost of $14.64 per share, with a total value of $101,016.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
AMEH stock traded up $1.08 during trading on Friday, reaching $16.11. 193,561 shares of the company were exchanged, compared to its average volume of 107,400. The stock has a market cap of $526.15 million, a price-to-earnings ratio of 55.55, a P/E/G ratio of 4.33 and a beta of -0.74. Apollo Medical Holdings Inc has a twelve month low of $13.36 and a twelve month high of $30.00. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.00 and a quick ratio of 2.00.
Apollo Medical (NASDAQ:AMEH) last released its quarterly earnings data on Monday, March 18th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.12 by ($0.20). The company had revenue of $105.46 million for the quarter. Apollo Medical had a return on equity of 4.87% and a net margin of 1.79%. On average, equities research analysts anticipate that Apollo Medical Holdings Inc will post 0.34 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. ExodusPoint Capital Management LP acquired a new position in Apollo Medical in the 1st quarter valued at approximately $208,000. Geode Capital Management LLC increased its position in Apollo Medical by 3.3% in the 1st quarter. Geode Capital Management LLC now owns 189,445 shares of the company’s stock valued at $3,470,000 after acquiring an additional 6,000 shares during the period. Northern Trust Corp increased its position in Apollo Medical by 5.9% in the 1st quarter. Northern Trust Corp now owns 118,464 shares of the company’s stock valued at $2,171,000 after acquiring an additional 6,581 shares during the period. Swiss National Bank increased its position in Apollo Medical by 5.0% in the 1st quarter. Swiss National Bank now owns 46,644 shares of the company’s stock valued at $855,000 after acquiring an additional 2,200 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Apollo Medical by 17.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 37,750 shares of the company’s stock valued at $692,000 after acquiring an additional 5,508 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.
AMEH has been the subject of a number of research analyst reports. ValuEngine upgraded shares of Apollo Medical from a “hold” rating to a “buy” rating in a research report on Friday, March 15th. Zacks Investment Research cut shares of Apollo Medical from a “hold” rating to a “sell” rating in a research report on Friday, March 29th.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Read More: What is a Market Correction?
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.